M&T Bank
MTCR

M&T Bank’s Metacrine, Inc. Common Stock MTCR Stock Holding History

M&T Bank’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,275
Closed -$50K – 1647
2021
Q2 		$50K Hold
13,275
– – ﹤0.01% 1524
2021
Q1 		$82K Buy
13,275
+1,572
+13% +$13.9K ﹤0.01% 1473
2020
Q4 		$92K Hold
11,703
– – ﹤0.01% 1587
2020
Q3 		$119K Buy
+11,703
New +$120K ﹤0.01% 1477

Other funds holding MTCR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

M&T Bank's MTCR Position: Q3 2021 in Review

M&T Bank sold out of Metacrine, Inc. Common Stock (MTCR) in Q3 2021, closing a stake of 13,275 shares — an estimated $50K sold.

M&T Bank first reported a position in MTCR in Q3 2020 and held it in 4 quarters. The position peaked at $119K in Q3 2020. 35 funds tracked by Wall St. Rank hold MTCR as of Q3 2021.

  • M&T Bank reported no remaining Metacrine, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • M&T Bank sold 13,275 Metacrine, Inc. Common Stock shares in Q3 2021, an estimated $50K.
  • M&T Bank first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • M&T Bank's Metacrine, Inc. Common Stock position peaked at $119K in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q3 2021.

Based on M&T Bank's 13F filing for Q3 2021, filed 28 Oct 2021.